Thyroid Functions of Newborn Babies Born to Mothers with Differentiated Thyroid Carcinoma Following Radioiodine Treatment at a Tertiary Hospital

Objective: The aim of the study was to investigate thyroid function newborn babies mothers with differentiated carcinoma (DTC) after receiving radioactive iodine (131I) therapy (RAIT). Materials and methods: During period 2009 2014, a total 1620 women had been treated 131I in division National Institute Nuclear Medicine & Allied Sciences (NINMAS). Patients were followed up at regular intervals systematically allowed conceive confirmation disease free condition. A retrospective review medical records done this study. Out patients, 1370 (84.6%) reproductive age group (18-44 years). Among 111 patients became pregnant 2 years RAIT. Age pregnancy ranged between 20 32 (24.8 ± 4.8). All well supplemented by levothyroxine maintained their Thyroid Stimulating Hormone (TSH) low normal range (0.1-1.0 mIU/L). Average serum thyroglobulin (Tg) level below <0.02 ng/dl. Would be requested estimate TSH newborns 7 15 days birth report us. They immediately reported test results babies. Results: One hundred fourteen DTC received RAIT conceived mean 24.8± 4.8 (19-38 114 110 (96.5%) papillary cancer (PTC) 4 (3.5%) follicular (FTC). 30-100 mci. outcome pregnancies 108 (97.30%) delivered healthy euthyroid 3 (2.70%) miscarriages. from 0.52 -16 mIU/L (3.69 3.19) Conclusion: This showed that young did not have any deleterious effects on subsequent pregnancies. born radioiodine treatment evaluated TSH. Bangladesh J. Med. 25(2): 88-92, 2022